Cargando…
Using artificial intelligence to identify patients with migraine and associated symptoms and conditions within electronic health records
BACKGROUND: Real-world evidence (RWE)—based on information obtained from sources such as electronic health records (EHRs), claims and billing databases, product and disease registries, and personal devices and health applications—is increasingly used to support healthcare decision making. There is v...
Autores principales: | Riskin, Daniel, Cady, Roger, Shroff, Anand, Hindiyeh, Nada A., Smith, Timothy, Kymes, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349448/ https://www.ncbi.nlm.nih.gov/pubmed/37452338 http://dx.doi.org/10.1186/s12911-023-02190-8 |
Ejemplares similares
-
Development and validation of a novel model for characterizing migraine outcomes within real-world data
por: Hindiyeh, Nada A., et al.
Publicado: (2022) -
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study
por: Silberstein, Stephen, et al.
Publicado: (2020) -
Evaluating the clinical utility of the patient‐identified most bothersome symptom measure from PROMISE‐2 for research in migraine prevention
por: Lipton, Richard B., et al.
Publicado: (2022) -
Prospect of Artificial Intelligence Based on Electronic Medical Record
por: Lee, Suehyun, et al.
Publicado: (2021) -
Applications of Artificial Intelligence to Electronic Health Record Data in Ophthalmology
por: Lin, Wei-Chun, et al.
Publicado: (2020)